Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Active not recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Weight Loss 2Anorexia 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × anamorelin × 1 year × Clear all
NCT03637816 2026-04-15

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
25 enrolled
Thoracic

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡